1 of 1
Story summary
- A bipartisan group of senators introduced the INSULIN Act to cap private-insurance insulin costs at $35 per month.
- The bill follows a 2022 law that capped costs for Medicare beneficiaries.
- Despite manufacturer efforts, many patients remain excluded, especially those with self-insured plans.
- Advocates say the legislation could help young adults with diabetes costs, but past bills have stalled.
